Article
Distinct genetic architecture of coronary heart disease in dyslipidemia patients.
BMC medical genomics - 12 May 2026
Huang Man, Song Xiuli, Zhou Shuni, Zhang Haiyan, He Lijuan, Chen Yanghui, Chen Guangzhi, Ding Hu, Jiang Jiangang, Wang Yan, Wang Dao Wen, Sun Yang, Wang Hong
Abstract excerpt
BACKGROUND: Mutations of LDLR, APOB and PCSK9 have been well-established to cause hypercholesterolemia while the pathogenic effects of LPL has been confirmed by cohorts and functional studies in hypertriglyceridemia. However, these mutations do not fully account for all dyslipidemia, and it remains unexplained why some patients with dyslipidemia develop coronary heart disease (CHD) while others do not. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
